Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

EQT Infrastructure to partner with EdgeConneX to develop data centers for global hyperscale customers

· This investment will enable expansion into new markets around the world to fulfill customers’ global data center capacity requirements and become their provider of choice · This new partnership will build out hundreds of megawatts of new data center capacity to support future cloud, AI and other critical digital infrastructure requirementsEQT is pleased to announce that the EQT Infrastructure VI fund (“EQT Infrastructure”) has agreed to partner with EdgeConneX to build and operate high-powered and purpose-built data centers for hyperscale customers around the world, expanding into new

Resolutions of Annual General Meeting in SameSystem A/S.

Company Announcement No. 1-2024Copenhagen, 5 January 2024 SameSystem A/S will delist from Nasdaq First North Growth Market Denmark. The last day of trading shares in SameSystem A/S on Nasdaq First North Growth Market Denmark will be Thursday, 18 January 2024. The Annual General Meeting of SameSystem A/S took place on January 5, 2024, at SameSystem A/S, Rentemestervej 2A, 2400 København NV, in accordance with the agenda. The board of directors elected Søren Brinkmann, attorney-at-law, as chairman of the meeting. Leif Vestergaard, Chairman of the Board of SameSystem, accounted

Cereno Scientific releases Insights video season 2 episode 7 with Prof. Benza

Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that episode 7 of season 2 in the Insights Video Series has been released. The video highlights the rationale and design of the Phase 2 clinical trial in PAH with drug candidate CS1, a controlled-release formulation of valproic acid. It further provides commentary on the recently published research article in the medical journal Pulmonary Circulation about the design of the Phase II study with CS1. Participating in the video is Raymond L. Benza,

Zwipe AS announces management change

OSLO, NORWAY – 5 January 2024 – Zwipe has appointed Hugo Petit as interim CFO with Zwipe’s current CFO and Head of IR, Danielle Glenn, deciding to leave the company to join a capital markets advisory and consulting firm Ms. Glenn has been responsible for Zwipe’s capital markets activities, including the two rights issues in 2023. She has also been instrumental in designing Zwipe’s overall strategic, operating, and investment plans and in restructuring the company to maximize financial flexibility and liquidity. Mr. Petit will join Zwipe as soon as possible, bringing over 20 years of

Pihlajalinna Plc: Managers’ transactions

Pihlajalinna Plc      Managers’ transactions     5 January 2024 at 3:00 p.m. Pihlajalinna Plc: Managers’ transactions Pihlajalinna Plc has received the following notification on 3 January 2024: Person subject to the notification requirementName: Tuomas HyyryläinenPosition: Chief Executive Officer Issuer: Pihlajalinna OyjLEI: 74370058MTRLEDOCHV67 Notification type: INITIAL NOTIFICATIONReference number: 48530/4/4____________________________________________Transaction date: 2024-01-02Outside a trading venueInstrument type: SHAREISIN: FI4000092556Nature of

Net Asset Value

NET ASSET VALUE 1. NET ASSET VALUE British & American Investment Trust PLC announces that, as at 29[th] December 2023, the value of the group’s investments and cash at banks was £5.6 million (net of £612,500 interim ordinary and preference dividends paid on 21[st] December,  equivalent to 1.75 pence per share fully diluted) and the unaudited consolidated net asset value of the company was not less than  15.9 pence per ordinary share on a fully diluted basis.   End

TORM plc capital increase in connection with delivery of one 2015-built MR vessel and one 2010-built LR2 vessel

With reference to Company Announcement no. 22 dated 09 November 2023 where TORM plc (“TORM") announced the acquisition of eight LR2 product tanker vessels, TORM plc has increased its share capital by 652,768 A-shares (corresponding to USD 6,527.68) as a result of the delivery of the first of the eight LR2 vessels.   With reference to Company Announcement no. 23 dated 09 November 2023 regarding plc’s Q3 2023 results where TORM announced the acquisition of four MR product tanker vessels, TORM plc (“TORM”) has increased its share capital by 660,714 A-shares (corresponding to USD 6,607.14)

BLAST Premier Expands To 16 Teams For 2024 With GamerLegion, Falcons, Team Spirit and Virtus.pro All Joining

BLAST Premier is expanding ahead of the 2024 season with the addition of four new BLAST Premier Affiliate Member Teams. Falcons, GamerLegion, Team Spirit and Virtus.pro will all join the BLAST Premier circuit in time for Spring Groups, kicking off later this month in the BLAST Copenhagen studios. Following Evil Geniuses' decision to sell their Member Team slot at the close of 2023, BLAST received high interest from across the Counter-Strike ecosystem, with Cloud9 later being announced as the newest BLAST Premier Member Team. Following this interest, BLAST has decided to create

SOFTSWISS Helps Operators Safeguard EUR 13m+ in 2023

In 2023, SOFTSWISS, an innovative technology company, reported a substantial outcome as the Anti-Fraud team within its SOFTSWISS Managed Services solution helped secure over 13 million euro for clients.In 2023, the Anti-Fraud team efficiently handled over 100,000 tasks, demonstrating a remarkable 62% increase in its year-on-year output. These encompassed diverse issues, ranging from operator requests and player verifications to reports of suspicious activities. Predominantly, instances of fraud detected by the SOFTSWISS Anti-Fraud team were related to bonus abuse, with a smaller

Stayble Therapeutics presents the final data from the phase IIb study

Stayble Therapeutics AB ("Stayble" or the "Company") today presents the final data analysis of the Company's phase IIb study with STA363 against chronic disc-related back pain (degenerative disc disease, “DDD”). Consistent with the preliminary topline analysis communicated in a previous press release, the subgroup analyses verify previously announced results where no difference in pain between placebo and active groups could be detected. In patients who received the higher dose of STA363, a statistically significant difference in disc intensity was observed and in both active doses a

Notice to Extraordinary General Meeting in Akobo Minerals AB (publ)

N.B. The English text is an unofficial translation.The shareholders of Akobo Minerals AB (publ), company registration no 559148-1253 (the “Company”), are hereby invited to participate in the Extraordinary General Meeting (“EGM”) to be held on 2 February, 2024 at 15.00 at Södra Allégatan 13, 413 01 Gothenburg, Sweden.   Participation Shareholders that wish to participate in the procedures at the EGM must: -         on 25 January, 2024, be recorded as shareholders in the share register kept by Euroclear Sweden AB (temporary registration for shareholders registered at the Norwegian

Akobo Minerals announces Extraordinary General Meeting as a step to prepare for the required funding of the Segele Mine

OSLO, 5 January 2024: Akobo Minerals AB  (Euronext and Frankfurt: AKOBO) (OTCQX:AKOBF). The Scandinavian-based Ethiopian gold exploration and boutique mining company intends to call for an Extraordinary General Meeting ("EGM") to be held on 2 February January 2024, at Södra Allégatan 13, Gothenburg, Sweden. The purpose of the EGM is to secure a necessary authorization for the Board of Directors to issue new shares with deviation from the pre-emption rights of

Transforming the future of retail: Pricer showcases digital in-store automation solutions at NRF

Pricer, the global leader in retail in-store automation and communication, will exhibit at the National Retail Federation (NRF)’s Big Show, taking place in New York from January 14 to 16.Exhibiting at booth #6457, Pricer solutions, recognized the world over by Tier 1 retail, will showcase its latest in-store automation and communication solutions that serve the rapidly growing smart retail market. Pricer transforms the shelf edge in real-time to improve store operations—with dynamic pricing, up-to-date product availability, and streamlined in-store order fulfillment and replenishment

Webstep ASA: Minutes of extraordinary general meeting

Oslo, 5 January 2024: The extraordinary general meeting of Webstep ASA (the “Company”) was virtually held today,  5 January 2024. The minutes of the extraordinary general meeting are attached.Kjell Magne Leirgulen is the new chairman of the board of directors in Webstep ASA. Leirgulen is CEO of Embron Group AS, which is a related party to the Company’s largest shareholder, Embro Eiendom AS. Leirgulen was previously the CEO of InfoCare, as well as director of Sales and Customer Service at Posten Norge AS. Mr. Leirgulen has served at the board of directors in Webstep ASA since May 2023, and

BioStock: Saniona selects clinical candidate for major depressive disorder

After encouraging results showing rapid reversal of stress-induced depression, Saniona selects SAN2465 as a clinical candidate for major depressive disorder. The announcement comes less than a week after Saniona chose SAN2355 as the first clinical candidate from its Kv7 epilepsy program. BioStock reached out to Saniona’s CEO Thomas Feldthus for a comment.Read the full interview with Thomas Feldthus at biostock.se: https://www.biostock.se/en/2024/01/saniona-selects-clinical-candidate-for-major-depressive-disorder/ This is a press release from BioStock - Connecting Innovation & Capital.

Cereno Scientific’s innovative study design of the Phase II study of CS1 in PAH published in renowned journal Pulmonary Circulation

Cereno Scientific (Nasdaq First North: CRNO B), a company developing innovative treatments for common and rare cardiovascular disease, today announced that a research article on the innovative study design of the ongoing Phase II study of drug candidate CS1 in pulmonary arterial hypertension (PAH) has been published in the renowned medical journal Pulmonary Circulation.The research article describes how the design of clinical trials is important to fully understand the mechanisms and benefits of new treatments. Numerous potential pharmacological treatments for PAH have shown promise in

BioStock Investor Pitch: Oncoinvent

Oncoinvent’s CEO Anders Månsson visited BioStock’s studio to talk about the development of the radiopharmaceutical Radspherin for peritoneal carcinomatosis. In his presentation, he delves into the results from the phase I/IIa studies with Radspherin and the upcoming clinical development plan. Furthermore, he talks about Oncoinvent as an investment opportunity and the unmet medical need for these cancer patients.Watch Anders Månsson present Oncoinvent at biostock.se : https://www.biostock.se/en/2024/01/biostock-investor-pitch-oncoinvent/ This is a press

Bioretec Ltd – Managers’ transactions

Bioretec Ltd      Managers’ transactions 5 January 2024 at 11.00 a.m. EETBioretec Oy - Managers' Transactions __________________________________________ Person subject to the notification requirement Name: Stephen Industries Inc Oy Position: Closely associated person (X) Legal person  (1):Person Discharging Managerial Responsibilities In Issuer Name: Kustaa Poutiainen Position: Member of the Board Issuer: Bioretec Oy LEI: 7437008736AG7HY51K13 Notification type: INITIAL NOTIFICATION Reference number: 48652/4/6 ____________________________________________

Allgon opens a new office in Denmark

Gothenburg, January 5th, 2024. Further increasing its worldwide position in the industrial wireless communication field, Allgon announces the opening of the new Tele Radio subsidiary in Denmark. The company, Tele Radio Denmark ApS based in Svenstrup, is the 26th subsidiary that has opened its doors, giving Allgon Group presence in now 23 countries. The branch officially began operations in December 1st, 2023.Helene Kyo Johansen is leading Tele Radio Denmark as its General Manager and Sales Manager. Helene has a successful 13-year trajectory as product manager in Tele Radio’s sister

ZINZINO AB (PUBL): PRELIMINARY SALES REPORT 2023

Zinzino group total revenue increased 23% in Q4 and total revenue for the full year 2023 increased 23%, compared to the previous year. The revenue in December for Zinzino's sales markets increased by 23 % and amounted to SEK 152.4 (123.8) million. Faun Pharma's external sales decreased and amounted to SEK 5.0 (5.1) million. Overall, the Group increased revenues by 22% to SEK 157.4 (128.9) million compared with the previous year. Sales in Zinzino's sales markets increased by 24% in the fourth quarter of 2023 compared with the same period last year and amounted to SEK 511.2 (413.3)

Notification of managers’ and closely related parties’ transactions with Dampskibsselskabet NORDEN A/S’ shares in connection with share buy-back program

ANNOUNCEMENT NO. 5 - 5 JANUARY 2024   In connection with the announced share buy-back program in NORDEN, A/S Motortramp continuously sells shares pro rata and the market is to be informed accordingly – see the attached file and announcements nos. 186/23 and 187/23.   Kind regards, Dampskibsselskabet NORDEN A/S   Martin Badsted CFO     For further information: Stig Frederiksen, Head of Investor Relations, tel.: +45 32 71 08 55, e-mail: sfr@norden.com

Dicot invited to present at ESSM for the third time

Press release: Uppsala, Sweden, January 5, 2024. The pharmaceutical company Dicot's preclinical research results have been selected to be presented at the European Society for Sexual Medicine's conference in February. It is the third year in a row that Dicot will present at Europe's largest event in the field of sexual medicine.The European Society for Sexual Medicine (ESSM) is Europe's leading scientific organization in sexual medicine whose annual conference brings together prominent researchers and doctors from all over the world. The ESSM Scientific Council has selected Dicot's

Konecranes to modernize two cranes for Fortum Power & Heat at Finland’s largest hydropower plant

Photo: Fortum Power & HeatKonecranes will modernize the industrial cranes at Fortum Power & Heat’s turbine hall in Imatra, Finland to ensure a continued steady supply of electricity for over 50,000 households annually. The order was booked in November 2023, with deliveries and installation scheduled for October 2024. The modernization of the two aging cranes at the Imatra Hydropower Plant, which started operations in 1929, will enhance performance and extend the cranes' service life. The project involves working within the confines of a protected historical building, adding

There are no items matching the current filter
There are no more items matching the current filter
Back to top